Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Head of Teaching at Puerto Vallarta Regional Hospital with a strong focus on hormone therapy and minimally invasive procedures.

• Specializes in hormone therapy for prostate cancer
• Extensive experience in minimally invasive surgical procedures
• Certified in biomagnetism by the Higher Institute of Biomagnetism
• Skilled in various medical and dermatological treatments

A radiation oncologist with specialized training in prostate cancer hormone therapy, Dr. Sridhar P.S. brings extensive academic and clinical expertise to HCG Manavata Cancer Centre.

• Over 30 years of experience of experience in radiotherapy
• Diplomate of National Board in radiotherapy
• Active member of key oncology associations
• Practices evidence-based hormone therapy protocols

Dr. Borde has handled over 30,000 PET scans and 1,000 thyroid cancer patients at HCG Manavata Cancer Centre.

• 11 years of experience of experience in nuclear medicine
• Specializes in radioiodine and Lu-177 RN therapies
• Published papers in medical journals
• Proficient in all types of nuclear scans and PET-CT

Dr. Raj Nagarkar has performed over 50,000 cancer surgeries with a focus on improving patients' quality of life.

• 30 years of experience of experience in surgical oncology
• Trained at Tata Memorial Hospital and Royal College of Surgeons
• Specializes in breast and thoracic surgical oncology
• Professor for DNB Superspecialty Surgical Oncology
• Involved in 200+ clinical trials

Presented research on stomach cancer at the elite Gastrointestinal Cancer Symposium by American Society of Clinical Oncology. Dr. Shaunak specializes in targeted therapies with a focus on the molecular basis of cancer.

• Completed DNB in Medical Oncology from Indraprastha Apollo Hospital
• Former Registrar in Medical Oncology at Jawaharlal Nehru Cancer Hospital
• Delivered lectures at International Winter School of Oncology at AIIMS
• Specializes in hormone therapy for prostate cancer

10,000+ major surgeries performed with a focus on minimally invasive techniques – Dr. Banswal brings exceptional expertise to hormonal prostate cancer cases.

• Specializes in gastrointestinal cancers with 15 years of experience of surgical oncology experience
• Fellowship-trained at Tata Medical Centre – a leader in cancer treatment
• Published multiple national and international research papers
• Known for ethical approach and excellent patient outcomes

Dr. Ahmer Arif Shaikh specializes in surgical oncology with a focus on oral cancer and functional rehabilitation at HCG Manavata Cancer Centre.

• 15 years of experience of experience in surgical oncology
• Expertise in organ preservation and functional rehabilitation
• Proficient in major maxillofacial and head & neck surgeries
• Fellowship-trained in Head & Neck Surgical Oncology
• Published researcher in the field

Dr. Shruti Kate specializes in medical oncology with a focus on hormone therapy for prostate cancer. She trained at Tata Memorial Hospital, one of India's top cancer centers.

• DM Medical Oncology from Tata Memorial Hospital
• Expert in lung, breast, and genitourinary cancers
• Member of ASCO, ESMO, and other oncological societies
• Presented research at World Conference on Lung Cancer
• Special interest in immunotherapy and metronomic therapy